Volgen
Sakshi Gulati
Sakshi Gulati
Cancer Research UK Manchester Institute
Geverifieerd e-mailadres voor cruk.manchester.ac.uk
Titel
Geciteerd door
Geciteerd door
Jaar
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ...
Nature 545 (7655), 446-451, 2017
16562017
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
M Gerlinger, S Horswell, J Larkin, AJ Rowan, MP Salm, I Varela, R Fisher, ...
Nature genetics 46 (3), 225-233, 2014
13442014
Allele-specific HLA loss and immune escape in lung cancer evolution
N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ...
Cell 171 (6), 1259-1271. e11, 2017
11392017
Fc effector function contributes to the activity of human anti-CTLA-4 antibodies
FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ...
Cancer cell 33 (4), 649-663. e4, 2018
5312018
Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors
FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ...
Immunity 46 (4), 577-586, 2017
4092017
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study
SM Domchek, S Postel-Vinay, SA Im, YH Park, JP Delord, A Italiano, ...
The Lancet Oncology 21 (9), 1155-1164, 2020
3202020
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
DG Rothwell, M Ayub, N Cook, F Thistlethwaite, L Carter, E Dean, N Smith, ...
Nature medicine 25 (5), 738-743, 2019
2342019
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
N Kanu, E Grönroos, P Martinez, RA Burrell, X Yi Goh, J Bartkova, ...
Oncogene 34 (46), 5699-5708, 2015
1832015
Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkers
S Gulati, P Martinez, T Joshi, NJ Birkbak, CR Santos, AJ Rowan, ...
European urology 66 (5), 936-948, 2014
1722014
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
F Chemi, DG Rothwell, N McGranahan, S Gulati, C Abbosh, SP Pearce, ...
Nature medicine 25 (10), 1534-1539, 2019
1682019
The combination of the PARP inhibitor olaparib and the WEE1 inhibitor AZD1775 as a new therapeutic option for small cell lung cancer
A Lallo, KK Frese, CJ Morrow, R Sloane, S Gulati, MW Schenk, F Trapani, ...
Clinical Cancer Research 24 (20), 5153-5164, 2018
1452018
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution
R Fisher, S Horswell, A Rowan, MP Salm, EC de Bruin, S Gulati, ...
Genome biology 15, 1-15, 2014
872014
Understanding cancer mechanisms through network dynamics
TMK Cheng, S Gulati, R Agius, PA Bates
Briefings in functional genomics 11 (6), 543-560, 2012
472012
Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer
S Mohan, M Ayub, DG Rothwell, S Gulati, B Kilerci, A Hollebecque, ...
Scientific reports 9 (1), 11610, 2019
452019
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics
A Lallo, S Gulati, MW Schenk, G Khandelwal, UW Berglund, IS Pateras, ...
British journal of pharmacology 176 (3), 436-450, 2019
392019
Cancer networks and beyond: interpreting mutations using the human interactome and protein structure
S Gulati, TMK Cheng, PA Bates
Seminars in cancer biology 23 (4), 219-226, 2013
272013
In vitro antimicrobial activity of ethanolic extract of Aloe vera against some bacterial and fungal species
P Prashar, S Gulati, V Koul, S Sehgal, S Sehgal
Adv Bio Tech 11 (3), 32-33, 2011
132011
Relapse models for clear cell renal carcinoma
S Gulati, S Turajlic, J Larkin, PA Bates, C Swanton
The Lancet Oncology 16 (8), e376-e378, 2015
52015
Publisher correction: pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
F Chemi, DG Rothwell, N McGranahan, S Gulati, C Abbosh, SP Pearce, ...
Nature medicine 26 (7), 1147-1147, 2020
22020
clear cell Renal Cell Carcinoma: Biomarkers and Networks
S Gulati
UCL (University College London), 2016
22016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20